
Newsletter – November 16th 2022
Upperton Launches ASAPprime® Shelf-Life Stability Testing Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients
Upperton Launches ASAPprime® Shelf-Life Stability Testing Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients
In Vitro Testing of Dry Powder Nasal Delivery Devices Successful nasal drug delivery of dry powder formulations requires a delivered dose that can penetrate beyond
Latest News from Upperton Pharma Solutions Successful MHRA Inspection Upperton is delighted to announce that during the last week of July 2022 the UK MHRA
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK NG7 2TN,
Phone: +44 (0) 115 855 7050
Email: contact@upperton.com